Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies

References

• RoeserHPLeeGRNachtSCartwrightGEThe role of ceruloplasmin in iron metabolismJ Clin Invest197049240824175480864
   PubMed Web of Science ®Google Scholar
• HarrisZLDurleyAPManTKGitlinJDTargeted gene disruption reveals an essential role for ceruloplasmin in cellular iron effluxProc Natl Acad Sci199996108121081710485908
   PubMed Web of Science ®Google Scholar
• JeongSYDavidSGlycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous systemJ Biol Chem2003278271442714812743117
   PubMed Web of Science ®Google Scholar
• HarrisZLTakahashiYMiyajimaHSerizawaMMacGillivrayRTGitlinJDAceruloplasminemia: molecular characterization of this disorder of iron metabolismProc Natl Acad Sci199592253925437708681
   PubMed Web of Science ®Google Scholar
• HarrisZLKlompLWGitlinJDAceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasisAm J Clin Nutr199867Suppl972S977S9587138
   PubMed Web of Science ®Google Scholar
• ConnorJRMenziesSLSt MartinSMMufsonEJA histochemical study of iron, transferrin, and ferritin in Alzheimer’s diseased brainsJ Neurosci Res19923175831613823
   PubMed Web of Science ®Google Scholar
• SmithMAHarrisPLSayreLMPerryGIron accumulation in Alzheimer’s disease is a source of redox-generated free radicalsProc Natl Acad Sci199794986698689275217
   PubMed Web of Science ®Google Scholar
• PonkaPHereditary causes of disturbed iron homeostasis in the central nervous systemAnn N Y Acad Sci2004101226728115105272
   PubMed Web of Science ®Google Scholar
• JinLWangJZhaoLDecreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s diseaseBrain2011134505821109502
   PubMed Web of Science ®Google Scholar
• Martinez-HernandezRMontesSHiguera-CallejaJPlasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson’s disease patients: A pilot studyNeurochem Res2011362111211521706376
   PubMed Web of Science ®Google Scholar
• HarrisZLMoritaHGitlinJDThe biology of human ceruloplasminMesserschmidtAMulti-Copper OxidasesSingaporeWorld Scientific1997285305
   Google Scholar
• TorsdottirGGudmundssonGKristinssonJSnaedalJJohannessonTCeruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson’s disease: A case control studyNeuropsychiatr Dis Treat20095555919557100
   PubMed Web of Science ®Google Scholar
• TorsdottirGKristinssonJSveinbjörnsdottirSSnaedalJJohannessonTCopper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson’s diseasePharmacol Toxicol19998523924310608487
   PubMedGoogle Scholar
• TorsdottirGSveinbjörnsdottirSKristinssonJSnaedalJJohannessonTCeruloplasmin and superoxide dismutase (SOD1) in Parkinson’s disease: A follow-up studyJ Neurol Sci2006241535816352311
   PubMed Web of Science ®Google Scholar
• SnaedalJKristinssonJGunnarsdottirSOlafsdottirABaldvinssonMJohannessonTCopper, ceruloplasmin and superoxide dismutase in patients with Alzheimer’s disease. A case-control studyDement Geriatr Cogn Disord199892392429701674
   PubMed Web of Science ®Google Scholar
• TorsdottirGKristinssonJSnaedalJJohannessonTCeruloplasmin and iron proteins in the serum of patients with Alzheimer’s diseaseDement Geriatr Cogn Disord Extra20111366371
   Google Scholar
• ZeccaLYoudimMBRiedererPConnorJRCrichtonRRIron, brain ageing and neurodegenerative disordersNat Rev Neurosci2004586387315496864
   PubMed Web of Science ®Google Scholar
• AltamuraSMuckenthalerMUIron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosisJ Alzheimer’s Dis200916879895
   PubMed Web of Science ®Google Scholar
• BarnhamKJMastersCLTorsdottirGBushAINeurodegenerative diseases and oxidative stressNat Rev Drug Discov2004320521415031734
   PubMed Web of Science ®Google Scholar
• JohannessonTKristinssonJTorsdottirGSnaedalJSerúlóplasmín og járn. Tengsl viđ Alzheimersjúkdóm og ParkinsonsjúkdómCeruloplasmin (Cp) and iron in connection with Parkinson’s disease (PD) and Alzheimer’s disease (AD)Laeknabladid201298531537 Icelandic (with English summary)23043066
   PubMed Web of Science ®Google Scholar
• TorsdottirGKristinssonJHreidarssonSSnaedalJJohannessonTCopper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down’s syndromePharmacol Toxicol20018932032511903959
   PubMedGoogle Scholar
• TorsdottirGKristinssonJSnaedalJCase-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: A short reviewJ Neurol Sci2010299515420851426
   PubMed Web of Science ®Google Scholar
• ArnalNCristalliDOde AlanizMJTMarraCAClinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relativesBrain Res2010131911813020026314
   PubMed Web of Science ®Google Scholar
• BergDHochstrasserHSchweitzerKJRiessODisturbance of iron metabolism in Parkinson’s disease – ultrasonography as a biomarkerNeurotox Res2006911316464747
   PubMed Web of Science ®Google Scholar
• HochstrasserHBauerPWalterUCeruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson’s diseaseNeurology2004631912191715557511
   PubMed Web of Science ®Google Scholar
• VassilievVHarrisZLZattaPCeruloplasmin in neurodegenerative diseasesBrain Res Rev20054963364016269323
   PubMedGoogle Scholar
• ZeccaLCasellaLAlbertiniANeuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s diseaseJ Neurochem20081061866187518624918
   PubMed Web of Science ®Google Scholar
• UverskyVNNeurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegenerationCell Tissue Res200431822524115258850
   PubMed Web of Science ®Google Scholar
• IndenMKitamuraYAbeMTamakiATakataKTaniguchiTParkinsonian rotenone mouse model: Reevaluation of long-term administration of rotenone in C57BL/6 miceBiol Pharm Bull201134929621212524
   PubMed Web of Science ®Google Scholar
• HinenoAKanekoKYoshidaKIkedaSCeruloplasmin protects against rotenone-induced oxidative stress and neurotoxicityNeurochem Res2011362127213521706374
   PubMed Web of Science ®Google Scholar
• BlennowKAlzheimers sjukdom – patofysiologiAlzheimer’s disease, pathophysiologyInformation från Läkemedelsverket20027/82134 Swedish
   Google Scholar
• YuraszeckTMNeveuPRodriguez-FernandezMRobinsonAKosikKSDoyleFJIIIVulnerabilities in the tau network and the role of ultrasensitive points in tau pathophysiologyPLoS Comput Biol2010611e100099721085645
   PubMed Web of Science ®Google Scholar
• TexelSJXuXHarrisZLCeruloplasmin in neurodegenerative diseasesBiochem Soc Trans2008361277128119021540
   PubMed Web of Science ®Google Scholar
• ConnorJRMenziesSLCellular management of iron in the brainJ Neurol Sci1995134Suppl33448847543
   PubMed Web of Science ®Google Scholar
• GaggelliEKozlowskiHValensinDValensinGCopper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis)Chem Rev20061061995204416771441
   PubMed Web of Science ®Google Scholar
• SmithMAZhuXTabatonMIncreased iron and free radical generation in preclinical Alzheimer’s disease and mild cognitive impairmentJ Alzheimers Dis20101936337220061651
   PubMed Web of Science ®Google Scholar
• NunomuraAPerryGAlievGOxidative damage is the earliest event in Alzheimer’s diseaseJ Neuropathol Exp Neurol20016075976711487050
   PubMed Web of Science ®Google Scholar
• SchragMMuellerCOyoyoUSmithMAKirschWMIron, zinc and copper in the Alzheimer’s disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinionProg Neurobiol20119429630621600264
   PubMed Web of Science ®Google Scholar
• QuintanaCBellefqihSLavalJYStudy of the localization of iron, ferritin, and hemosiderin in Alzheimer’s disease hippocampus by analytical microscopy at the subcellular levelJ Struct Biol2006153425416364657
   PubMed Web of Science ®Google Scholar
• PatelBNDunnRJJeongSYZhuQJulienJPDavidSCeruloplasmin regulates iron levels in the CSN and prevents free radical injuryJ Neurosci200222156578658612151537
   PubMed Web of Science ®Google Scholar
• BrewerGJKanzerSHZimmermanEACelminsDFHeckmanSMDickRCopper and ceruloplasmin abnormalities in Alzheimer’s diseaseAm J Alzheimers Dis Other Demen20102549049720631161
   PubMed Web of Science ®Google Scholar
• SparksDLSchreursBGTrace amounts of copper in water induce beta–amyoid plaques and learning deficits in a rabbit model of Alzheimer’s diseaseProc Natl Acad Sci2003100110651106912920183
   PubMed Web of Science ®Google Scholar
• SquittiRPasqualettiPDal FornoGExcess of serum copper not related to ceruloplasmin in Alzheimer’s diseaseNeurology2005641040104615781823
   PubMed Web of Science ®Google Scholar
• SquittiRBressiFPasqualettiPLongitudinal prognostic value of serum “free” copper in patients with Alzheimer’s diseaseNeurology200972505519122030
   PubMed Web of Science ®Google Scholar
• SquittiRGhidoniRScrasciaFFree copper distinguishes mild cognitive impairment subjects from healthy elderly individualsJ Alzheimers Dis20112323924820930297
   PubMed Web of Science ®Google Scholar
• HoogenraadTUParadigm shift in treatment of Alzheimer’s disease: zinc therapy now a conscientious choice for care of individual patientsInt J Alzheimers Dis2011Article ID 492686
   Google Scholar
• CapoCRArcielloMSquittiRFeatures of ceruloplasmin in the cerebrospinal fluid of Alzheimer’s disease patientsBiometals20082136737218060472
   PubMed Web of Science ®Google Scholar
• ChoiBSZhengWCopper transport to the brain by the blood-brain barrier and blood-CSF barrierBrain Res20091248142119014916
   PubMed Web of Science ®Google Scholar
• BucossiSVentrigliaMPanettaVCopper in Alzheimer’s disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studiesJ Alzheimers Dis20112417518521187586
   PubMed Web of Science ®Google Scholar
• SveinbjörnsdottirSHicksAAJonssonTFamilial aggregation of Parkinson’s disease in IcelandN Engl J Med20003431765177011114315
   PubMed Web of Science ®Google Scholar
• PalssonPAGrimssonHDemyelination in lambs from ewes which feed on seaweedsProc Soc Exper Biol Med19538351852013088893
   PubMed Web of Science ®Google Scholar
• PalssonPAGrimssonHFjöruskjögur. Copper deficiency in lambsBúnađarrit1954663250 Icelandic
   Google Scholar
• HollingworthPHaroldDSimsRCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s diseaseNat Genet20114342943621460840
   PubMed Web of Science ®Google Scholar